Clinical Trials on Constipation Drug Induced in Finland

Total 335 results

Olympic Seafood AS

Completed

Safety and Tolerability of Krill Powder Supplement in Slightly Overweight People With Moderately Elevated Blood Pressure

Adverse Drug Event | Side Effects of Drugs

Finland
Kuopio University Hospital

Completed

Opioid Induced Bowel Dysfunction in Patients Undergoing Spinal Surgery (oksineukir)

Constipation

Finland
Kuopio University Hospital
Admescope Ltd

Active, not recruiting

Opioid Induced Bowel Dysfunction in Patients Undergoing Cesarean Section (oksisektio)

Pain, Postoperative | Constipation

Finland
Kyowa Kirin Pharmaceutical Development Ltd
Apices Soluciones S.L.

Completed

Real World Observational Study of Naloxegol for Patients With Cancer Pain Diagnosed With OIC. (NACASY)

Opioid Induced Constipation

Netherlands, Sweden, Finland, Denmark, Spain, France, Germany, Greece, Italy, United Kingdom
Helsinki University Central Hospital

Terminated

Pain Medication After Ambulatory Surgery

Pain, Postoperative | Medication Adherence | Adverse Drug Event

Finland
AstraZeneca

Completed

Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation

Opioid-Induced Constipation (OIC)

United States, Australia, Slovakia, Germany
AstraZeneca

Completed

A 12-week Extension of the Phase III Study (D3820C00004) to Assess the Effect and Safety of NKTR-118 in Patients With Non-cancer-related Pain and Opioid-induced Constipation

Opioid-Induced Constipation (OIC)

United States, Germany, Australia, Slovakia
Helsinki University Central Hospital

Recruiting

Aggravated Airway Inflammation: Research on Biological Treatment (Mepolizumab) (AirGOs-biol)

Chronic Rhinosinusitis With Nasal Polyps | Asthma, Aspirin-Induced

Finland
Brown University
National Institute on Drug Abuse (NIDA)

Completed

The Rhode Island Prescription and Illicit Drug Study (RAPIDS)

Drug Overdose | Opioid Overdose

United States
Brown University
National Institute on Drug Abuse (NIDA); New York University

Active, not recruiting

Preventing Overdose Using Information and Data From the Environment (PROVIDENT)

Drug Overdose | Opioid Overdose

United States
Finnish Institute for Health and Welfare
European Commission; Hospital District of Helsinki and Uusimaa

Completed

Oral Fluid Screening Devices

Drug-impaired Driving

Finland
Johanna Kujala

Completed

Detection of Paracetamol Concentration in Blood-, Saline- and Urine Samples - a Validation Study for a Novel Technique

Healthy | Drug Mechanism

Finland
Kuopio University Hospital

Completed

The Function of Gastrointestinal Tract During Pregnancy (umpiraskaus)

Constipation

Finland
Orion Corporation, Orion Pharma

Completed

Comparison of PEG Solutions With and Without Electrolytes in the Treatment of Constipation (PEGorion)

Constipation

Finland
Tampere University Hospital
Deaconess Foundation; A-Clinic Foundation

Recruiting

A Cross-Sectional Observational Study on Retained Drug Needle Fragments in People Who Use Intravenous Drugs

Soft Tissue Injuries | Substance Dependence | Foreign Bodies | Drug Abuse, Intravenous | Needle Injury

Finland
University of Helsinki
Social Insurance Institution, Finland; City of Lohja, Services for Aged People and other collaborators

Completed

Development of a Coordinated, Community-Based Medication Management Model for Home-Dwelling Aged in Primary Care

Polypharmacy | Inappropriate Prescribing | Drug Therapy, Combination

Finland
Bausch Health Americas, Inc.
Pfizer

Completed

Study Evaluating Long-Term Safety of MOA-728 in Participants With Opioid-Induced Constipation

Constipation

Canada, United States, Colombia, Korea, Republic of, Australia, Spain
Forest Laboratories
Ironwood Pharmaceuticals, Inc.

Completed

Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered to Patients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain

Opioid-Induced Constipation

United States
Sucampo Pharma Americas, LLC
Sucampo Pharmaceuticals, Inc.

Completed

Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone (OPAL)

Opioid-Induced Bowel Dysfunction

United States, Canada
Cubist Pharmaceuticals LLC
GlaxoSmithKline

Completed

Study 767905/008 Extension Study: Alvimopan for Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects

Cancer | Bowel Dysfunction

United States, France, Canada, Finland, Spain, Pakistan, Poland, Hong Kong, United Kingdom, Peru, New Zealand, Portugal, Russian Federation
Sucampo Pharma Americas, LLC
Sucampo Pharmaceuticals, Inc.

Completed

Opioid-induced Bowel Dysfunction (OBD) Pivotal Assessment of Lubiprostone (OPAL)

Opioid-induced Bowel Dysfunction

United States, Czechia, Germany, Belgium, Poland, Sweden, United Kingdom
Kuopio University Hospital

Unknown

Influence of CPB and Mini CPB to the Absorption of the Metoprolol (Minimeto)

Drug Absorption

Finland
University of Rhode Island

Not yet recruiting

Developing a Positive Approach to Substance Use Prevention in North American Indian Adolescents

Alcohol Drinking | Tobacco Use | Drug Use

United States
AstraZeneca

Terminated

Assessment of Efficacy and Safety in Relieving Opioid-induced Constipation in Patients With Cancer-related Pain

Opioid-Induced Constipation

Croatia, United States, Bulgaria, United Kingdom, Poland, Romania, Belgium, Puerto Rico, Slovakia, Australia, South Africa, Czech Republic, Germany, Spain
Purdue Pharma LP

Completed

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Low Back Pain

United States
Pro-Change Behavior Systems
IMS Health

Completed

Iwin: Individual Well-Being Navigator

Other Drug Substance Abuse

United States
Helsinki University Central Hospital
University of Helsinki

Recruiting

KF2022#3-trial: Effect of Tea and Cola Beverage on Absorption of Risperidone Oral Solution (KF2022#3)

Psychosis | Food-drug Interaction

Finland
Baystate Medical Center
National Institute on Drug Abuse (NIDA); The Miriam Hospital; Boston Medical... and other collaborators

Completed

Prescribe to Save Lives (PTSL)

Opioid-Related Disorders | Drug Overdose

United States
Purdue Pharma LP

Completed

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Low Back Pain

United States, Poland, Czech Republic, Italy
Brown University

Completed

Rapid Self-Testing to Prevent Fentanyl Overdose Among Young People Who Use Drugs (RAPiDS2)

Accidental Overdose of Opiate

United States
Finnish Foundation for Alcohol Studies

Completed

Magnesium After Alcohol Withdrawal Treatment

Alcohol-Induced Disorders

Finland
Braintree Laboratories

Completed

A Pilot Efficacy Evaluation of BLI-801 as a Laxative in Constipated Adults

Constipation

United States
Dana-Farber Cancer Institute
National Cancer Institute (NCI)

Completed

Treatment of Acute Lymphoblastic Leukemia in Children

Leukemia | Drug/Agent Toxicity by Tissue/Organ

United States, Canada
Helsinki University Central Hospital
Tampere University Hospital

Enrolling by invitation

Feasibility of Switching Fluoropyrimidine Due to Cardiotoxicity Study (CardioSwitch)

Solid Tumor

Denmark, Norway, Sweden, Finland, Netherlands, Iceland, Ireland
Women's Hospital HUS

Completed

Spinal Fentanyl or Epidural Analgesia in the Early First Phase of Induced Labor

Labor Pain | Induced; Birth

Finland
Sucampo Pharma Americas, LLC
Takeda

Completed

Lubiprostone for Children With Constipation

Constipation - Functional

United States, United Kingdom, Netherlands, Poland, Belgium, France, Canada
Tampere University

Completed

Recurrence of Acute Alcoholic Pancreatitis

Recurrent Acute Pancreatitis

Finland
Sucampo Pharma Americas, LLC
Sucampo AG

Completed

Lubiprostone in Children With Functional Constipation

Constipation - Functional

United States, United Kingdom, Canada, Netherlands, Poland, Belgium, France
Oulu University Hospital

Unknown

Assessment of Chemotherapy-induced Peripheral Neurotoxicity Using a Point-of-care Nerve Conduction Study Device (APPS)

Cancer

Finland
SK Life Science, Inc.

Completed

A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation

Chronic Idiopathic Constipation

United States
Forest Laboratories
Ironwood Pharmaceuticals, Inc.

Completed

Phase III, Randomized, Double-Blind, Placebo-Controlled, Trial of Linaclotide Administered to Patients With Chronic Constipation

Chronic Constipation

United States, Canada
Mundipharma Research GmbH & Co KG

Completed

Optimisation of Hydromorphone - Naloxone Ratio for the Treatment of Pain (HMX3501)

Constipation

Romania, Switzerland, Israel, Belgium, Germany, Australia, Austria, Czech Republic, Denmark, Finland, France, Netherlands, Poland, United Kingdom
Kuopio University Hospital

Withdrawn

Naloxone Methadone Combination (NAMEKO) (NAMEKO)

Opiate Dependence

Finland
Kuopio University Hospital
University of Eastern Finland

Completed

Electronic Compliance Monitoring in Opioid Substitution Treatment (EHSO)

Opiate Dependence

Finland
Forest Laboratories
Ironwood Pharmaceuticals, Inc.

Completed

Safety and Efficacy of Linaclotide in Patients With Chronic Constipation and Prominent Abdominal Bloating

Constipation | Chronic Constipation

United States, Canada
Finnish Institute for Health and Welfare

Completed

Comparative Trial Of Disulfiram, Naltrexone And Acamprosate In The Treatment Of Alcohol Dependence (DNA)

Alcohol Dependence

Finland
Forest Laboratories
Ironwood Pharmaceuticals, Inc.

Completed

A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)

Functional Constipation in Children Ages 6-17 Years

United States, Canada
Helsinki University Central Hospital

Unknown

Effect of an Electronic Reminder System on Direct Oral Anticoagulant and Oral Diabetes Medication Adherence

Diabetes Mellitus, Type 2 | Anticoagulant Drugs

Finland
University of Helsinki

Completed

The Effect of Valproate on Benzodiazepine Withdrawal Severity

Substance Withdrawal Syndrome

Finland
University of Helsinki

Completed

Randomised Open-label Multicenter Study Evaluating Ciprofloxacin in Severe Alcoholic Hepatitis

Alcoholic Hepatitis | Alcoholic Cirrhosis

Finland

Clinical Trials on Constipation Drug Induced in Finland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Peru

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations